Opening https://www.businesswire.com/news/home/20230316005661/en/Merck-Provides-Update-from-Open-Label-Arm-of-Phase-2-KeyVibe-002-Trial-Evaluating-MK-7684A-a-Coformulation-of-Vibostolimab-and-Pembrolizumab-in-Previously-Treated-Patients-with-Metastatic-Non-Small-Cell-Lung-Cancer-NSCLC